| Literature DB >> 30612940 |
Qingfei Jiang1, Jane Isquith2, Maria Anna Zipeto2, Raymond H Diep2, Jessica Pham2, Nathan Delos Santos2, Eduardo Reynoso2, Julisia Chau2, Heather Leu2, Elisa Lazzari2, Etienne Melese3, Wenxue Ma2, Rongxin Fang4, Mark Minden5, Sheldon Morris6, Bing Ren7, Gabriel Pineda8, Frida Holm2, Catriona Jamieson9.
Abstract
Adenosine deaminase associated with RNA1 (ADAR1) deregulation contributes to therapeutic resistance in many malignancies. Here we show that ADAR1-induced hyper-editing in normal human hematopoietic progenitors impairs miR-26a maturation, which represses CDKN1A expression indirectly via EZH2, thereby accelerating cell-cycle transit. However, in blast crisis chronic myeloid leukemia progenitors, loss of EZH2 expression and increased CDKN1A oppose cell-cycle transit. Moreover, A-to-I editing of both the MDM2 regulatory microRNA and its binding site within the 3' UTR region stabilizes MDM2 transcripts, thereby enhancing blast crisis progenitor propagation. These data reveal a dual mechanism governing malignant transformation of progenitors that is predicated on hyper-editing of cell-cycle-regulatory miRNAs and the 3' UTR binding site of tumor suppressor miRNAs.Entities:
Keywords: 3′ UTR; ADAR1; RNA hyper-editing; cancer stem cell; cell cycle; chronic myeloid leukemia; epitranscriptome; leukemia; microRNAs; progenitors; self-renewal
Mesh:
Substances:
Year: 2019 PMID: 30612940 PMCID: PMC6333511 DOI: 10.1016/j.ccell.2018.11.017
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743